Information for Triple agonist
Page information·measured at build time
Technical and provenance information about Triple agonist. All figures on this page are measured from the emitted page rather than declared.
Basic information
| Display title | Triple agonist |
|---|---|
| Default sort key | Triple agonist |
| Namespace | Article (main) |
| Page kind | Concept |
| Page length (source, bytes) | 4,269 |
| Rendered word count | 489 |
| Internal wiki links on the page | 23 |
| Defined citations | 4 |
| Top-level sections | 3 |
| Subsections | 0 |
| Tables | 0 |
| Figures | 0 |
| Infobox | Yes — concept |
| Maintenance banners | None |
| Indexing by robots | Allowed |
Edit history
| Page creator | MazdutideMads |
|---|---|
| Date of page creation | 21 September 2024 |
| Latest editor | ExenatideEzra |
| Date of latest edit | 17 July 2026 |
| Total number of edits | 30 |
| Total number of distinct authors | 26 |
| Minor edits | 9 |
| Automated (bot) edits | 2 |
| Recent number of edits (last 90 days) | 3 |
| Talk page posts | 4 |
Principal authors
| Editor | Edits | Share | Declared focus |
|---|---|---|---|
| ReceptorRhoda | 2 | 6.7% | incretin biology and receptor pharmacology |
| CagriCass | 2 | 6.7% | GLP-1 receptor agonists and related compounds |
| CiteBot | 2 | 6.7% | copy-editing and the manual of style |
| CuriousCallum | 2 | 6.7% | GLP-1 receptor agonists and related compounds |
| MazdutideMads | 1 | 3.3% | GLP-1 receptor agonists and related compounds |
| NPOV_Nadia | 1 | 3.3% | policy, notability and deletion |
| BetaCellBoyd | 1 | 3.3% | incretin biology and receptor pharmacology |
| RedirectRini | 1 | 3.3% | categorisation and navigation |
| EndpointEnid | 1 | 3.3% | clinical trials and evidence appraisal |
| ColdChainCleo | 1 | 3.3% | peptide synthesis and supply chain |
| SchematicScout | 1 | 3.3% | diagrams and figures |
| GMP_Gita | 1 | 3.3% | compounding law and drug regulation |
Category membership
- Category:Dual and triple agonists — 5 member pages
- Category:Receptor pharmacology — 10 member pages
- Category:Articles describing unapproved compounds — 21 member pages